Lona Biotherapeutics Ltd.
PrivateLast Round
Private Placement
Dec 18, 2025
Est. Valuation
$670M
Total Funding Raised
$104.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lona Biotherapeutics Ltd. is a biotechnology company that develops AI-guided, personalized TCR-T cell therapies for the treatment of blood cancers and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lona Biotherapeutics Ltd. Comparables
Compare Lona Biotherapeutics Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Immatics N.V. | 80% | |
| TScan Therapeutics | 79% | |
| Lion TCR | 78% |
Lona Biotherapeutics Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Dec 18, 2025 | ||||
| IPO | Sep 17, 2020 | ||||
| Series B | Jun 4, 2020 | ||||
| Grant | Nov 15, 2018 | ||||
| VC Round | Nov 2, 2017 | ||||
Grant | Apr 13, 2017 |
Lona Biotherapeutics Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series B |
| Ligand Pharmaceuticals | Private Placement |
| Janus Henderson Group | Series B |
| TCG Crossover | Private Placement |
| LifeSci Venture Partners | Series B |
| Dolby Family Ventures | Series A, VC Round |
| Kayne Anderson Capital Advisors | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 18, 2025
$90M round led by Commodore Capital, Perceptive Advisors, and TCG Crossover.
- Nov 15, 2018
$1M grant received from Alzheimer's Association.
Lona Biotherapeutics Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lona Biotherapeutics Ltd.'s valuation, stock price, and market status.
Is Lona Biotherapeutics Ltd. a public or private company?
Lona Biotherapeutics Ltd. is a private company.
What is the current stock price of Lona Biotherapeutics Ltd.?
Lona Biotherapeutics Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Lona Biotherapeutics Ltd. worth (valuation)?
Lona Biotherapeutics Ltd.'s valuation is estimated at $670.0M based on funding round data.
Can I buy Lona Biotherapeutics Ltd. stock?
Lona Biotherapeutics Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Lona Biotherapeutics Ltd.'s last funding round?
Lona Biotherapeutics Ltd.'s most recent funding round was Private Placement on September 17, 2020.
Who are the main investors in Lona Biotherapeutics Ltd.?
Key investors in Lona Biotherapeutics Ltd. include TCG Crossover, Perceptive Advisors, Commodore Capital.
Will Lona Biotherapeutics Ltd. IPO soon?
No public IPO plans have been announced for Lona Biotherapeutics Ltd..
How can I track Lona Biotherapeutics Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lona Biotherapeutics Ltd.'s secondary market activity and sign up for updates.